Roy D. Baynes

Director, Travere Therapeutics, Inc.; Director, Natera, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.4M

Companies

Latest trade

Jun 12, 2026

Companies

Travere Therapeutics, Inc.Director −$2.5M Natera, Inc.Director −$2.8M

Trades

TVTX Sold 4,500 shares at $50.00 · planned $0.2M Jun 12

TVTX Sold 4,500 shares at $46.65 · planned $0.2M May 5

TVTX Sold 9,750 shares at $44.22 · planned $0.4M May 1

TVTX Sold 32,750 shares at $41.29 · planned $1.4M Apr 14

TVTX Sold 10,000 shares at $33.00 · planned $0.3M Apr 6

NTRA Sold 7,668 shares at $223.08 · planned $1.7M Nov 20

NTRA Sold 5,112 shares at $215.00 · planned $1.1M Nov 19

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.